Tetraphase Pharma (TTPH) Misses Q4 EPS by 1c

Tetraphase Pharma (NASDAQ: TTPH) reported Q4 EPS of ($0.61), $0.01 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.37 million.

For earnings history and earnings-related data on Tetraphase Pharma (TTPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c